» Articles » PMID: 32448557

A Perspective on Multi-target Drugs for Alzheimer's Disease

Overview
Specialty Pharmacology
Date 2020 May 26
PMID 32448557
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) has a complex pathophysiology that includes aggregation of pathological proteins, impaired neurotransmission, increased oxidative stress, or microglia-mediated neuroinflammation. Therapeutics targeting only one of these AD-related subpathologies have not yet been successful in the search for a disease-modifying treatment. Therefore, multi-target drugs (MTDs) aiming simultaneously at several subpathologies are expected to be a better approach. However, the concept of MTD is inherently connected with several limitations, which are often ignored during MTD design and development. Here, we provide an overview of the MTD approach and discuss its potential pitfalls in the context of AD treatment. We also put forward ideas to be used in the rational design of MTDs to obtain drugs that are effective against AD.

Citing Articles

Mitochondrial Dysfunction in Neurodegenerative Diseases.

Yang H Cells. 2025; 14(4).

PMID: 39996748 PMC: 11853439. DOI: 10.3390/cells14040276.


Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors.

Bindra S, Mostafa E, Abdelgawad M, Selim S, Kumar S, Mathew B RSC Med Chem. 2025; .

PMID: 39925735 PMC: 11799932. DOI: 10.1039/d4md00837e.


Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition.

Yoo J, Lee J, Ahn B, Han J, Lim M Chem Sci. 2025; 16(5):2105-2135.

PMID: 39810997 PMC: 11726323. DOI: 10.1039/d4sc06762b.


Recent Advances in the Search for Effective Anti-Alzheimer's Drugs.

Ogos M, Stary D, Bajda M Int J Mol Sci. 2025; 26(1.

PMID: 39796014 PMC: 11720639. DOI: 10.3390/ijms26010157.


Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease.

Vahid Z, Eskandani M, Dadashi H, Vandghanooni S, Rashidi M Heliyon. 2024; 10(23):e40756.

PMID: 39717593 PMC: 11664286. DOI: 10.1016/j.heliyon.2024.e40756.